← Leaderboards
Katja Kiseljakvassiliades
University Of Colorado Denver
$1,049,975
Attributed
$1,049,975
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $210K · FY2018–24$250K$187.5K$125K$62.5K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,049,975 · 1
VA$0 · 1
By mechanism
K08$1,049,975 · 1
I01$0 · 1
Top collaborators
- Margaret E. Wierman2 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Nina S Kadan-Lottick$5,510,109
- Wilbur A Franklin$9,400,239
- Sonia Castro Flores$16,461,738
- Scott I Bearman$3,107,851
- Paul A Bunn$21,859,370
Others in their field
Other Emerging Leaders on “In Vitro”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Leonard Freedmand · Leidos Biomedical Research, Inc.$68,796,314
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$41,541,738
- John Damon Chodera · Sloan-Kettering Inst Can Research$34,949,884
- Tony Moody · Duke University$34,777,314
Research focus
In VitroMouse ModelExperimental StudyGrowthMalignant NeoplasmsMolecularDatabasesEndocrineChemotherapyGenomicsKinase InhibitorBioinformaticsClinical TrialsMitoticAreaCellsAdrenal Gland CancerDna DamageCell CycleAdrenocortical CarcinomaCell LineGeneticIn VivoNew Therapeutic Target
Grant awards (7)
Targeting Kinases in Novel Preclinical Models of Adrenocortical Carcinoma$0
I01 · FY2024 · VA · contact PI
Targeting Kinases in Novel Preclinical Models of Adrenocortical Carcinoma$0
I01 · FY2023 · VA · contact PI
Identifying and Characterizing Therapeutic Targets in Adrenal Cancer$209,995
K08 · FY2022 · CA · contact PI
Identifying and Characterizing Therapeutic Targets in Adrenal Cancer$209,995
K08 · FY2021 · CA · contact PI
Identifying and Characterizing Therapeutic Targets in Adrenal Cancer$209,995
K08 · FY2020 · CA · contact PI
Identifying and Characterizing Therapeutic Targets in Adrenal Cancer$209,995
K08 · FY2019 · CA · contact PI
Identifying and Characterizing Therapeutic Targets in Adrenal Cancer$209,995
K08 · FY2018 · CA · contact PI